IconOVir Bio

IconOVir Bio, Inc. is a preclinical biotechnology company pioneering the next generation of oncolytic virus therapies to improve treatment for cancer patients. IconOVir has discovered multiple differentiated oncolytic virus candidates with robust tumor selectivity, intravenous administration potential, and the ability to broadly infect tumor cells.